- PPARgamma Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
-
Han JY, Kim YJ, Kim L, Choi SJ, Park IS, Kim JM, Chu YC, Cha DR
- KMID: 1713829
- J Korean Med Sci.
- 2010 Jan;25(1):35-41.
- doi: 10.3346/jkms.2010.25.1.35
The peroxisome proliferator activated receptor (PPAR)gamma agonist is used as antidiabetic agent with antihyperglycemic and antihyperinsulinemic actions. Beyond these actions, antifibrotic effects have been reported. We examined antifibrotic effects of... -
- CITED
-
- Close
- SHARE
-
- Close
- Associations between Oxidized LDL to LDL Ratio, HDL and Vascular Calcification in the Feet of Hemodialysis Patients
-
An WS, Kim SE, Kim KH, Bae HR, Rha SH
- KMID: 1778150
- J Korean Med Sci.
- 2009 Jan;24(Suppl 1):S115-S120.
- doi: 10.3346/jkms.2009.24.S1.S115
Cardiovascular mortality is associated with vascular calcification (VC) in hemodialysis (HD) patients. The present study was designed to find factors related with medial artery calcification on the plain radiography of... -
- CITED
-
- Close
- SHARE
-
- Close
- Flexible Initial Dosing of Atorvastatin Based Upon Initial Low-Density Lipoprotein Cholesterol Levels in Type 2 Diabetic Patients
-
Atorvastatin Study Group in Korea
- KMID: 1382658
- Korean J Intern Med.
- 2008 Mar;23(1):22-29.
- doi: 10.3904/kjim.2008.23.1.22
BACKGROUND/AIMS: We used flexible starting doses and early titration of atorvastatin to determine the rate of achievement of a low-density lipoprotein cholesterol (LDL-C) target for hyperlipidemic patients with type... -
- CITED
-
- Close
- SHARE
-
- Close
